Associated Papers
BRCA2 deficiency and replication stress drive APOBEC3-Mediated genomic instability.
Situ K et al.
Nature Communications, 2025
Defining the genome-wide mutagenic impact of APOBEC3 enzymes.
Németh E et al.
Methods in Enzymology, 2025
The cytidine deaminase APOBEC3A regulates nucleolar function to promote cell growth and ribosome biogenesis.
McCool MA et al.
Plos Biology, 2024
APOBEC3A regulates transcription from interferon-stimulated response elements.
Taura M et al.
Proceedings of the National Academy of Sciences of the United States of America, 2022
Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity.
Green AM et al.
Embo Reports, 2021
Cas12a Base Editors Induce Efficient and Specific Editing with Low DNA Damage Response.
Wang X et al.
Cell Reports, 2020
Cytosine Deaminase APOBEC3A Sensitizes Leukemia Cells to Inhibition of the DNA Replication Checkpoint.
Green AM et al.
Cancer Research, 2017
Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity.
Horn AV et al.
Nucleic Acids Research, 2014
Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties.
Mitra M et al.
Nucleic Acids Research, 2014
Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
Narvaiza I et al.
Plos Pathogens, 2009
Select a paper to view details